Sung-Hyun Kim and Dong-Wook Kim (2015) “Comment on ‘Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors’”, Haematologica. Pavia, Italy, 100(3), pp. e120-e121. doi: 10.3324/haematol.2014.123232.